Mueller Brian 5
5 · BIOMARIN PHARMACEUTICAL INC · Filed Feb 13, 2026
Insider Transaction Report
Form 5
Mueller Brian
EVP, Chief Financial Officer
Transactions
- Award
Common Stock
[F1]2025-04-30$54.14/sh+375$20,301→ 100,156 total
Footnotes (1)
- [F1]Represents the shares acquired by the reporting person on April 30, 2025, pursuant to the issuer's Employee Stock Purchase Plan.
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact|2026-02-13